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Abstract: Maintained weight loss of five percent or more may reduce risk of breast cancer. We conducted a feasibility 
pilot study to assess adherence to an intensive 12 month diet and exercise weight control intervention aimed to achieve 
and maintain a five percent or greater weight loss as compared to a usual care group receiving written advice only.  
Overweight premenopausal women at increased risk of breast cancer were enrolled in a 12 month diet and exercise weight 
loss programme (n = 40) or a comparison group receiving usual care (n = 39). Changes in weight, general (DXA, 
bioelectrical impedance) and central adiposity (intra abdominal fat; MRI, waist), dietary intake, physical activity, cancer 
worry (Lerman score) and quality of life (SF-36) were assessed at 6 and 12 months, as well as long-term changes in 
weight and adiposity 12 and 42 months after the end of the intervention.  
Target weight loss (5%) was achieved by 55% of the intervention group at the end of the 12 month intervention but 
maintained by fewer at 24 (39%) and 54 months -(21%). Overall the intervention group achieved significant reductions in 
weight (mean [95% CI] -4.6 [-6.4 to -2.8] %), body fat (-4.0 [-5.2 to -2.7] ) kg, intra abdominal fat (-25.0 [-39.0 to -8.0])% 
and waist circumference (-4.0 [-6.8 to -2.0] cm) during the 12 month intervention and reported large reductions in intake 
of energy (-24.3 [-33.2 to -15.1] %), fat (-32 [-44 to -20] %), and alcohol (-35 [-52 to -13] %), and increased moderate 
activity (27 [7 to 44] minutes/day). These parameters did not change in the usual care group (all P<0.05). A small 
proportion of the usual care group lost and maintained >5% of their weight at 6 (16%), 12 (11%), 24 (11%) and 54 (13%) 
months (P<0.05 at all time points). The intervention increased physical well being (SF-36; P<0.05) but had no measurable 
effect on mental well being or cancer worry.  
Weight loss is achievable within our high risk women but not more so than in previous studies in the general population. 
Further studies are required to better understand factors which can promote compliance in women at increased risk of 
breast cancer. 
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INTRODUCTION 
 A family history (FH) of breast cancer is an important 
indicator of a woman’s risk of developing the disease. These 
high risk women are managed in cancer family history 
clinics which provide risk assessment, counseling, breast 
screening and, where appropriate, molecular genetic testing. 
An increasing body of evidence suggests risk of breast  
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cancer in women and particularly those at high risk is 
modifiable by lifestyle factors. Specifically data support the 
role of excess weight [1-5], central adiposity [6, 7] and the 
possible effects of sedentary behaviour [8] on risk which 
appear more important than intake of specific dietary factors 
such as fat [9] and fruit and vegetables [10]. Amongst BRCA 
mutation carriers excess weight [11, 12], lack of exercise and 
diet quality [13] have been linked to increased risk and 
earlier onset of breast cancer. These findings are, however, 
based on a limited number of mainly retrospective studies. 
The potential risk reduction with weight loss and exercise 
amongst high risk women needs to be tested in a large scale 
prospective intervention study.  
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 Data within the general and high risk population suggest 
significant breast cancer risk reduction with modest weight 
loss (5%) [14, 15]. However, even modest weight loss is 
known to be difficult to achieve and maintain in many 
patient groups [16]. Here we report a pilot study to assess 
uptake and adherence to a 12 month diet and exercise weight 
control intervention aimed to achieve and maintain a five 
percent or greater weight loss amongst high risk women 
[17]. We compared an intensive to standard written advice 
only to assess the relative effects of the two approaches. This 
will inform the feasibility and numbers required to power a 
future large scale weight loss breast cancer risk reduction 
trial. We also determined any effects of the intervention on 
quality of life and cancer worry to see whether these 
parameters were improved by the intervention and whether 
risk perception and level of cancer worry predicted 
adherence and could be potential targets to motivate 
adherence.  
 
Fig. (1). Recruitment and retention to study. 
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SUBJECTS AND METHODS 
Subjects  
 Attendees of our regional Family History Clinic (estima-
ted lifetime breast cancer risk of 16 – 40%) [18] aged 35 – 
45 received a mailed invitation to enter either a 12 month 
intensive diet and exercise weight loss programme or a usual 
care group receiving standard written advice only depending 
on their proximity to the hospital. Participants were required 
to have gained >7 kg weight since the age of 20, have 30% 
body fat, be sedentary, non-smokers, and premenopausal 
with no evidence of polycystic ovary syndrome [19] and 
were not taking oral contraceptives. They did not have 
diabetes, cardiovascular disease or previous history of 
cancer. Participants had previously received information of 
their genetic risk, and were attending annual mammographic 
screening. Uptake and retention within the two groups is 
shown in Fig. (1). All participants gave informed consent. 
The protocol was approved by the South Manchester Ethics 
Committee (Reference no 01/426).  
 
Fig. (2). Changes in weight, waist and body fat over 24 years in the intervention (n = 36) and usual care groups (n = 35). 
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Weight Loss Intervention 
 The intervention group was advised to follow an energy 
restricted diet providing 500-1000 kcal below their estimated 
energy requirements (1.4 times x estimated resting energy 
expenditure) [20] with 20% energy from protein, 30% from 
fat and 50% from carbohydrate. They were also instructed to 
increase exercise gradually to include at least five 30 minute 
sessions of moderate exercise (defined as 50–60% of age-
estimated maximal heart rate) each week [21], equivalent to 
an additional 1.4 kcal/kg/day energy expenditure. The 
intervention was designed to achieve a gradual weight loss 
of 0.5-1 kg/week and a weight loss of 5% or greater at 6 
months and maintenance of this at 12 months. Each 
participant received an individualised diet and a home based 
exercise plan from the study dietitian (MH) and exercise 
specialist (DA). To maximise compliance, they were asked 
to attend a weekly group exercise session for the first 12 
weeks, and monthly appointments with the study dietitian 
throughout the 12 month intervention to assess change in 
weight and reinforce diet and exercise recommendations. 
The intervention was based on the trans theoretical model of 
behaviour change. A range of cog-nitive behavioural tech-
niques such as self monitoring, obtaining peer/family support 
and stimulus control were encouraged to increase com-
pliance [22]. 
Usual Care Group 
 This group were given a leaflet providing general 
lifestyle advice to reduce risk of cancer; to lose weight, 
increase exercise, increase intake of fruit and vegetables and 
limit intake of alcohol, fat and meat [23]. They agreed to be 
monitored throughout the year to assess normal changes in 
diet and exercise behaviour and adiposity in clinic attendees. 
Study Protocol 
 Subjects in the intervention and usual care group were 
assessed at baseline, 6 and 12 months to determine any 
changes in weight, adiposity, dietary intake, level of physical 
activity, quality of life and cancer worry. Risk perception 
was assessed at baseline only. 
Weight Related Factors  
 Weight, height, waist and hip circumferences were 
assessed using standardised methods in the morning after a 
12 hour fast, wearing light clothing. Body circumferences 
were measured in triplicate [24]. Total body fat was mea-
sured both using a DXA whole body Hologic QDR 4500A 
scanner and V8.26a:3 software (Hologic Inc., Bedford, MA, 
USA) (coefficient of variation [CV]: fat mass 1.8%, lean 
muscle mass 0.6%) and using bioelectrical impedance (BI) 
(Tanita TBF-300A Tanita Europe BV Middlesex UK) (CV 
2%). Intra-abdominal fat (IAF) was measured using mag-
netic resonance imaging (MRI) with a single axial water 
suppressed image at the L2/L3 vertebra level, with the 
technician blinded to the group allocation. Overall 
standardised CV of IAF estimation was 7.3%.  
 
Changes in Diet and Physical Activity 
 Change in dietary intake was assessed using 4-day food 
diaries checked for completeness with the respondent. Mean 
energy, protein, fat and carbohydrate intake were estimated 
using the Compeat 4 Nutrition Analysis System (Carlson 
Bengston Consultants, London, UK). Change in physical 
activity was assessed using the validated 7-day physical 
activity recall questionnaire [25] expressed as kcal/kg/day. 
We also performed a 6 minute walk test as an objective 
measure of fitness [26].  
Cancer Risk Perception, Cancer Worry and Quality of 
Life  
 Each subject reported her personal perception of her risk 
of developing breast cancer through selection of the 
appropriate odds ratio value which ranges from 1:2 to 1:100 
with additional categories of 1 for "inevitable" and 1000 for 
"very unlikely" [27]. Personal risk accuracy was determined 
by comparing self-reported odds value for personal risk with 
actual odds value calculated by the clinician (e.g. 1 in 4). 
Women were classified as under, over or accurate reporters 
[28].  
 Worry about the risk of developing cancer and the impact 
of worry on daily functioning was assessed using the 
Lerman’s Cancer Worry Scale. Each item on this 6 item 
scale is scored from 1 to 4 giving a possible total score of 24. 
 Health related quality of life was assessed using the SF–
36 instrument reported as physical (physical functioning, 
role physical, bodily pain and general health scales) and 
mental (vitality, social functioning, role emotional and 
mental health) summary scores [29]. 
Follow Up Study  
 Long-term weight loss maintenance is most likely 
required for cancer risk reduction. We assessed long term 
changes in weight and adiposity, i.e. body fat (BI) and waist 
circumference, in both groups. All participants were invited 
for a review with the study dietitian 24 and 54 months after 
the start of the study i.e. 12 and 42 months after the end of 
the 12 month intervention.  
Statistics  
 Data are presented as the mean (95% confidence inter-
vals; CI), or geometric mean (95% CI) for the log transfor-
med variable intra-abdominal fat. We assessed changes in 
weight-related parameters, quality of life, cancer worry and 
diet and exercise behaviours at 6 and 12 months in the 
intervention group as compared to the usual care group using 
a last observation carried forward (LOCF) analysis of 
variance (ANOVA) adjusted for baseline levels of each 
parameter. The proportion of women achieving weight loss 
of ≥5% at 6 months and maintaining this at 12, 24, months 
were determined in the groups using a LOCF analysis. Since 
only 50% of the intervention group and 43% of the control 
group were reassessed at 54 month we also undertook a 
baseline observation carried forward analysis at this time  
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point. We explored factors which may be linked to 
successful long-term weight loss (>5%) by comparing pre-
intervention levels of cancer worry (Independent t test), 
personal risk perception scores (Mann-Whitney) and perso-
nal risk accuracy (Chi squared) between women achieving 
either greater than or less than 5% weight loss at 24 months. 
Researchers undertaking analyses of quality of life, cancer 
worry and risk perception data were blinded to the study 
group. Data were analysed using SPSS (version 14 SPSS 
Ltd, Chicago, IL, USA). A 2-sided statistical significance 
level of 5% was used. 
RESULTS  
 Our mail shot elicited an uptake of 13% to the inter-
vention group. Seventy–four percent did not respond, 9% 
were ineligible for medical reasons or were already losing 
weight. An earlier survey in our clinic suggests 50% of non 
responders to the mass (non-targeted) mailing had a normal 
BMI and thus would be ineligible [30]. Thus an estimated 
24% of eligible women were recruited. Correspondingly 
amongst women invited to the usual care group, 81% did not 
respond, 5% were not eligible; hence an estimated 24% of 
eligible women were recruited. There was no difference in 
age or risk of responders compared with non responders in 
either of the mailings (data not shown). 
 Characteristics of the intervention and usual care groups 
are shown in Table 1. Groups were comparable although the 
intervention group had a slightly higher body mass index 
(BMI) and lower predicted and perceived risk of breast  
 
cancer than the usual care group. These differences were not 
statistically significant.  
 The intervention group achieved significant reductions in 
weight (mean [95% CI] -4.6 [-6.4 to -2.8] %), body fat (-4.0 
[-5.2 to -2.7]) kg intra abdominal fat (-25.0 [-39.0 to -8.0] % 
and waist circumference (-4.0 [-6.8 to -2.0] cm during the 12 
month intervention weight mean (95% CI) = (-4.6 [-6.4 to -
2.8] %), body fat (-14.6 [-19.0 to –10.0] %), intra-abdominal 
fat (-25.0 [-39.0 to -8.0] % and waist circumference (-5.0 [-
8.1 to –1.2] cm) during the 12 month intervention, whilst 
these parameters did not change significantly in the usual 
care group (Table 2). The intervention group reported large 
reductions in dietary intake of energy (-24.3 [-33.2 to -15.1] 
%), fat (-32 [-44 to –20] %), and alcohol (-35 [-52 to -13] 
%). On average an additional 16 (5 to 32) minutes moderate 
intensity exercise/day by 6 months and 27 (7 to 44) minutes/ 
day by 12 months were undertaken. The usual care group did 
not report significant dietary changes but there was a short-
term increase in physical activity at 6 months which was not 
sustained at 12 months. At 12 months there was an objective 
improvement in fitness in the intervention group as 
compared to the usual care group assessed by the 6 minute 
walk test (P<0.05) (Table 3). 
 The intervention group experienced a significant increase 
in the physical aggregate quality of life score at 12 months 
(6%) which was unchanged in the usual care group (P=0.05). 
Neither the intervention nor usual care group experienced 
changes in mental aggregate quality of life or cancer worry 
scores. Neither of these scores appears to be influenced by 
weight loss (Table 2).  
Table 1. Baseline Characteristics of the Intervention and Usual Care Groups 
 
 Intervention  
 N = 40 
Usual care  
 N = 38 
Age (years) a 41.0 ± 3.0 40.2 ± 2.8  
Body mass index (Kg/m2) a 30.2 ± 7.0 28.3 ± 5.1 
Weight gain since aged 20 (kg) a 22.5 ± 14.1 17.2 ± 7.3 
Ethnicity (% Caucasian) 90 97 
Smoking: 
Current  
Never  
Ever 
 
0 
90 
10 
 
0 
82 
18 
Predicted lifetime breast cancer risk  (%) b 21 ± 5 27 ± 7 
Perceived lifetime breast cancer risk (%) c d 20 (10 – 100)  33 (1 – 50) 
 Accuracy of personal risk estimation (%) 
 Underestimate  
 Accurate  
 Overestimate 
 No estimates   
 
25 
39 
18 
18 
 
26 
32 
21 
20 
a mean ± SD 
b from Tyrer Cuzick model [21] 
c median (range) 
d Risk perception questionnaire [26] 
76     The Open Obesity Journal, 2010, Volume 2 Harvie et al. 
 We were able to reassess weight and body fat and waist 
in the majority of women at 24 months (36 intervention, 35 
usual care), but fewer at 54 months (20 intervention, 17 
usual care). Predictably both groups experienced increases in 
weight and body fat in the 12 months following the interven-
tion although waist remained static in the intervention group. 
Weight and waist increased above baseline measurements in 
the usual care group. Analysis of variance (ANOVA) using 
last observation carried forward values at 24 months adjusted 
for baseline level showed significant reductions in weight 
and waist were sustained in the intervention compared to the 
usual care group (P<0.01) (Fig. 2). Impedance measurements 
showed a non-significant reduction in body fat in the 
intervention compared to the usual care group, which reflects 
the variation in body fat measurements assessed with 
impedance (P=0.09) (Fig. 2). Mean difference in body fat 
mass by BI and DXA in our population was 0.36 kg. The 
limits of agreement (mean ± 2SD) between the two methods 
were -3.8 to +4.5 kg (-11 to +14%).  
 Target weight loss (≥5%) was achieved by 55% of the 
intervention group at the end of the 12 month intervention 
period with fewer maintaining this at 24 (39%) and 54 
months (LOCF 32% BOCF 21%). A small proportion of the 
usual care group receiving standard written advice lost and 
maintained (≥5%) of their weight at 6 (16%, P=0.03), 12 
(11%, P<0.0001), 24 (11%, P=0.01), and 54 months (LOCF 
17% BOCF 13%) (P=0.32).  
 We were unable to identify any psychological predictors 
of successful weight loss and maintenance. There was no 
difference in baseline cancer worry (P=0.55), personal risk 
perception score (P=0.28), or accuracy of risk perception 
Table 2. Changes in Weight, Adiposity, Cancer Worry and Quality of Life Over 12 Months in the Intervention and Usual Care 
Group  
 
  Baseline Change at 6 months  P value 3 Change at 12 months P value3 
Weight (kg) 1 
Intervention 
Usual Care  
 
80.1 (74.3 to 85.9) 
75.1 (71.5 to 80.4)  
 
-4.0 (-5.1 to -2.0) 
-0.4 (-1.3 to 1.6) 
 
<0.0001 
 
-3.9 (-5.2 to -2.2) 
 0.1 (-1.1 to 1.2) 
 
<0.0001 
Body fat (DXA) (kg) 1 
Intervention 
Usual Care 
 
30.8 (27.2 to 34.4)  
28.1 (25.0 to 31.1)  
 
-2.9 (-4.1 to -1.8)  
-0.1 (-0.8 to +0.5) 
 
<0.0001 
 
-4.0 (-5.2 to -2.7) 
 0.0 (-1.6 to 3.5) 
 
<0.0001 
Body fat (BI) (kg) 1 
Intervention 
Usual Care 
 
31.7 (27.6 to 35.8) 
29.4 (25.4 to 33.6) 
 
-2.4 (-3.6 to -1.2)  
-0.4 (-1.6 to 0.5) 
 
0.01 
 
-2.7 (-3.7 to -1.6)  
 0.5 (-1.6 to 0.7) 
 
<0.0001 
Intra abdominal fat (cm2) 2  
Intervention 
Usual Care 
 
85.1 (66.3 to 106.2) 
70.4 (58.3 to 85.2)  
 
0.88 (0.79 to 0.97) 
1.04 (0.92 to 1.18) 
 
0.04 
 
0.75 (0.61 to 0.92) 
0.95 (0.84 to 1.07) 
 
0.03 
Waist circumference (cm) 1 
Intervention 
Usual Care 
 
99.2 (94.2 to 104.2) 
95.5 (91.6 to 99.4) 
 
-4.0 (-6.7 to -2.2)  
-0.1 (-1.6 to 1.5)  
 
0.02 
 
 -4.0 (-6.8 to -2.0)  
  0.4 (-2.4 to 1.6)  
 
0.03 
Quality of life  
Physical aggregate score 1 
Intervention 
Usual Care 
  
 
53.2 (51.4 to 53.5) 
54.1 (52.1 to 56.1) 
  
 
1.3 (-0.8 to 3.4) 
1.1 (-1.2 to 3.5)  
 
 
0.78 
 
 
 3.0 (0.7 to 5.2)  
-0.4 (-3.4 to 2.6) 
  
 
0.05  
Quality of life 
Mental aggregate score 1 
Intervention 
Usual Care 
 
44.0 (40.8 to 47.2) 
47.2 (44.4 to 51.0) 
 
 0.2 (-4.3 to 4.7) 
-0.9 (-4.2 to 2.4)  
 
0.96 
 
 3.2 (-1.4 to 7.8) 
-0.4 (-3.4 to 2.6)  
 
0.99 
Cancer worry 1 
Intervention 
Usual Care 
 
11.3 (10.3 to 12.4)  
10.4 (9.4 to 11.3) 
 
 -0.2 (-1.0  to 0.6) 
  0.3 (-0.5 to 1.1)  
 
0.62 
  
 0.0 (-0.9 to 0.9) 
-0.7 (-1.6 to 0.3)  
 
0.50 
BI = bioelectrical impedance, DXA = dual-energy x-ray absorptiometry 
1 Mean (95% CI) for baseline values and mean (95% CI) change in LOCF value at 6 and 12 months. 
2 Geometric mean (95% CI) for baseline values and mean (95% CI) ratio of change in LOCF natural log values at 6 and 12 months. 
3 P value for analysis of variance comparing women in intervention and usual care groups adjusted for baseline value 
Baseline: Intervention 40    Usual care 39  6 months: Intervention 38    Usual care 38 12 months: Intervention 37   Usual care 38  
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(P=0.38) between women who had lost and maintained >5% 
weight loss at 24 months and women who did not lose 
weight. 
DISCUSSION 
Main Findings 
 This is the first study to report uptake and adherence to a 
weight loss intervention for breast cancer risk reduction 
amongst women at increased risk of breast cancer attending a 
Family History Clinic. Fifty–five percent of the intervention 
group achieved a clinically significant weight loss (>5%) by 
the end of 12 months, with an estimated 21 % maintaining 
this in the longer terms (54 months). In comparison a small 
proportion receiving usual care and standard written advice 
lost weight at 12 (11%) and 54 months (13 %). The interven-
tion reduced general and central adiposity and increased 
physical well being, but had no measurable effect on mental 
well being or cancer worry.  
Strengths of Study 
 We used a comprehensive range of valid measures to 
assess changes in general and central adiposity (DXA, BI, 
MRI), dietary intake (food diaries), physical activity (7-day 
recall), quality of life and cancer worry during the 12 month 
intervention. Excellent retention to both the intervention 
(94%) and usual care groups (94%) up to 24 months, and 
assessment of actual rather than self reported weights at all 
time points [31] allowed us to accurately assess long-term 
weight loss maintenance and the likely impact of the 
intervention for cancer risk reduction. However, the 
predictable larger drop out by 54 months limits the validity 
of our findings at this time point. We assessed long-term 
changes in body fat using bioelectrical impedance which is 
known to be a valid measure of changes in body fat with 
weight loss in women [32].  
Study Limitations 
 We have not examined the effects of a diet and exercise 
weight loss programme compared to usual care in the con-
text of a randomised controlled trial. In common with pre-
vious research we found randomisation to a no treatment 
group to be unacceptable in this group of women [33]. 
Groups were mainly comparable at baseline, the slightly 
higher starting BMI and lower actual and perceived breast 
cancer risk in the intervention group is unlikely to have 
affected our findings. We studied premenopausal, non smo-
king women. Adherence to the intervention and their effects 
may differ in different groups. For example adherence to 
chemoprevention has shown to be lower amongst smokers 
[34]. We focused on premenopausal women, however, 
weight loss is also likely to reduce risk amongst postmeno-
Table 3. Changes in Dietary Intake and Physical Activity Over 12 Months in the Intervention and Usual Care Group 
 
  Baseline  Change at 6 months  P value 2 Change at 12 months  P value2  
Energy (kcal) 1 
Intervention 
Usual Care 
 
2192 (1991 to 2393) 
2041 (1890 to 2192)  
 
 -536 (-743 to -329) 
 -85 (-210 to 40) 
 
<0.0001 
 
-600 (-800 to -396)  
 -81 (-240 to 76)  
 
<0.0001 
Total fat (g) 1 
Intervention 
Usual Care 
 
83.4 (73.4 to 93.6) 
76.7 (68.2 to 85.1) 
  
-25.0 (-34.1 to -15.2)  
 -3.2 (-10.7 to 4.2)  
 
<0.0001 
  
-26.0 (-34.0 to -17.0)  
 -4.0 (-13.0 to 5.0) 
 
<0.0001 
Saturated fat (g) 1 
Intervention 
Usual Care 
  
29.4 (25.0 to 33.8)  
28.9 (24.9 to 33.0) 
  
 -9.2 (-14 to -5.4)  
 -3.2 (-6.0 to 0.2)  
 
0.001 
 
-9.2 (-13.9 to -4.5)  
-3.2 (-6.9 to 0.6) 
 
0.001 
Alcohol (g) 1 
Intervention 
Usual Care 
 
15.9 (10.8 to 21.0)  
13.5 ( 9.0 to 18.3)  
 
-6.1 (-10.5 to -1.8) 
 1.6 (-1.9 to 5.0) 
 
0.005 
  
-7.7 (-11.7 to -3.7) 
 1.5 (-3.7 to 6.7) 
 
0.004 
 Total kcal/kg/day13 
Intervention 
Usual Care 
  
 33.2 (32.7 to 33.7) 
 33.6 (32.9 to 34.3) 
 
1.0(0.3 to 2.1)  
0.4(0.0 to 0.7)  
 
0.024 
 
 1.8 (0.5 to 2.9)  
 0.4 (-0.3 to 2.5)  
 
0.05 
Distance walked in 6 minutes1 4 
Intervention 
Usual Care 
 
 570 (549 to 591)  
 573 (549 to 598)  
  
35.9 (22.2 to 49.6) 
26.6 (11.8 to 41.4)  
 
0.34 
 
39.8 (22.2 to 57.4)  
10.7 (-11.7 to 33.1)  
 
0.03 
1 Mean (95% CI) for baseline values and mean (95% CI) change in LOCF value at 6 and 12 months. 
2 P value for analysis of variance comparing women in intervention and usual care groups adjusted for baseline value 
3 7 – day activity recall [24] 
4 6 minute walk test [25]  
Baseline: Intervention 40 Usual care 39  6 months: Intervention 38 Usual care 38 12 months: Intervention 37 Usual care 38 
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pausal women [35]. We did not include women at higher 
levels of risk (60-80% lifetime risk) who are known to carry 
BRCA mutations. We cannot predict adherence and uptake 
in this higher risk group who are likely to benefit from future 
weight control interventions [11].  
 Although we used a validated self-report questionnaire to 
assess physical activity of the participants, such methods are 
subject to the potential errors associated with over-estima-
tion of behaviour and future studies would be improved by 
use of objective monitoring of physical activity. Assessment 
of weight and anthropometrics was conducted by the study 
dietitian who was not blinded regarding study group 
assignment. 
COMPARISON WITH OTHER STUDIES 
 The modest uptake to the intervention (13%) reflects the 
usual response to mailed invitations [36]. The estimated 24% 
uptake amongst eligible women is considerably less than 
uptake to our recent red clover nutritional supplement trial 
(85%) [37] but more than the 11% recruited to chemopreven-
tion trials in our high risk women [33].  
 Approximately 55% of our high risk women achieved the 
target weight loss for risk reduction at 12 months, with 32% 
achieving long-term success. This compares to the 65-70% 
of high risk women who have been shown to comply with 5 
years of chemoprevention [34]. 
 Previous reports amongst women with a family history 
have focused on dietary modification and increasing exercise 
and have not aimed to reduce weight. Djuric et al. reported 
good long-term adherence to a low fat (< 20%) and increased 
fruit and vegetable (9 portions/day) intervention. After 12 
months, average daily fruit and vegetable intake increased 
from 4 to 10 portions, whilst fat intake (as percentage of 
energy) decreased from 34% to 16%. Adherence reduced at 
24 months to 7 portions of fruit and vegetables/day and 27% 
of energy from fat [38]. Likewise, 6 months of telephone 
counseling amongst sisters of young women recently 
diagnosed with breast cancer increased the numbers achiev-
ing targets for physical activity (at least 90 minutes of 
moderate exercise/week) by 14% and for fruit and vegetable 
intake (>5 portions of fruit and vegetables/day) by 12% [39].  
 The proportion of our intervention group achieving short- 
and long-term weight loss is comparable with those seen in 
other patient groups at 20-30% [16, 40, 41]. Interestingly, a 
number receiving written advice only (11%) achieved weight 
loss through self management as also reported in the general 
population [41]. Our study population of women at increased 
risk of breast cancer does not appear to be more motivated to 
adhere to a weight loss intervention than other groups of 
women, but this would need to be confirmed in other studies. 
However, the significant reductions in general (-13%) and 
particularly central (-25%) adiposity may be beneficial 
amongst these high risk women who have increased central 
fat distribution [42, 43].  
 Participants in our study had comparable cancer worry 
and risk perception scores to those previously reported seen 
in our population at increased breast cancer risk [44]. Weight 
loss and adherence to the diet and exercise recommendations  
 
did not appear to impact on cancer worry. Cancer worry is 
known to decrease with interventions which substantially 
decrease risk, such as bilateral prophylactic mastectomy 
[45], but not with previous lifestyle interventions [39], 
perhaps because women with genetic risk do not perceive 
lifestyle interventions to reduce risk.  
 Neither cancer worry nor risk perception appeared to 
influence adherence to the intervention. Moderate, but not 
high levels of worry can motivate attendance at mammo-
graphic screening, but little is known about the effect on 
other behaviours [46, 47]. A previous analysis in our popu-
lation did not link level of risk to adherence to chemopreven-
tion agents [34]. Weight loss was linked to improvements in 
the physical, but not mental well being, quality of life 
measures, which has recently been reported amongst 
participants losing weight in the Diabetes Prevention 
Programme [48]. 
CONCLUSION  
 We have shown that weight loss is achievable within in a 
population of women at increased risk of breast cancer but 
not more than reported in other groups of women. The null 
associations between weight loss, cancer worry and risk 
perception discounts breast cancer risk reduction as a major 
motivator for lifestyle adherence in this group. Further 
psychosocial studies are required to better understand the 
reasons for low uptake/poor compliance in such studies and 
behavioural factors which promote compliance in this 
population. Such studies should be grounded in one of the 
psychological theories of behaviour change. Novel dietary 
approaches and modes of delivery for weight loss for cancer 
risk reduction are required. Future trials may test alternative 
approaches, such as intermittent energy restriction [49], or 
use of emerging technologies to communicate information, 
provide feedback and support to populations attending high 
risk clinics [50]. 
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